Case Study: LOPA Explained at PSCI India Conference 2025
Session Title: Layer of Protection Analysis (LOPA)Speaker: Yashpal Singh<br>Event: PSCI India Conference 2025<br>Session Type: Conference Technical Session<br>
Background: The PSCI India Conference 2025 is a leading industry forum that brings together pharmaceutical EHS, quality, engineering, and supply chain professionals to promote safe, responsible, and compliant operations. The conference focuses on process safety, risk management, and global best practices across the pharmaceutical supply chain.
Session Objectives
The session aimed to:
- Explain the purpose and importance of LOPA in pharmaceutical operations
- Clarify the difference between Safeguards and Independent Protection Layers (IPLs)
- Demonstrate when and how LOPA should be applied
Session Agenda
The presentation covered both conceptual understanding and practical application, including:
- Introduction to Layer of Protection Analysis (LOPA)
- Difference between Safeguards and IPLs
- Objectives of LOPA
- When to use LOPA
- Basic LOPA concepts
- LOPA Methodology – Step-by-Step
- Independent Protection Layers (IPL)
- Risk Criteria and Target Frequencies
- Case Study – Layer of Protection Analysis
- LOPA documentation and reporting
- Software tools for LOPA
- Regulatory and standards references
Key Learning Outcomes
Participants gained the ability to:
- Understand LOPA as a semi-quantitative risk assessment tool
- Correctly differentiate Safeguards vs IPLs
- Apply risk criteria and target frequencies in decision making
- Strengthen linkage between HAZOP and LOPA
- Improve technical justification during audits and regulatory reviews
Value Delivered
- Improved clarity on risk-based process safety decisions
- Reduced ambiguity in safeguard and IPL crediting
- Enhanced alignment with PSCI principles and global standards
- Increased competence of EHS and process safety professionals in LOPA application
Conclusion
The LOPA session delivered by Yashpal Singh at the PSCI India Conference 2025 successfully addressed a critical knowledge gap in pharmaceutical process safety. By combining theory, methodology, and practical case studies, the session enabled participants to better understand and apply LOPA in real-world pharmaceutical operations.
This knowledge aligns strongly with the mission of HSE Process Safety Academy (HSE-PSA) to promote practical, standards-aligned, and industry-focused process safety education, contributing to safer and more resilient pharmaceutical supply chains.
Video Link
Watch the training session here: